Maryse Lapeyre‐Mestre
Biographic Data
| ID | 7623121 |
|---|---|
| NAME | Maryse Lapeyre‐Mestre |
| GIVEN NAMES | Maryse |
| FAMILY NAME | Lapeyre‐Mestre |
| SIGNATURE | MESTRE M L |
| AFFILIATIONS | Laboratoire Epidémiologie et Analyses en Santé Publique : Risques, Maladies Chroniques et Handicaps |
| ORCID | 0000-0002-5494-5873 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Response to “Before a diagnosis of secondary catatonia due to chronic nitrous oxide use is made, all alternative causes must be ruled out”
International audience
First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use
Healthcare use according to deprivation among French Alzheimer's Disease and Related Diseases subjects
Introduction: Pluriprofessional and coordinated healthcare use is recommended for Alzheimer's Disease and Related Diseases (ADRD). Despite a protective health system, France is characterized by persistent and significant social inequalities in health. Although social health inequalities are well documented, less is known about social disparities in healthcare use in ADRD, especially in France. Therefore, this study aimed to describe healthcare us…
Evolution of the Addictovigilance Signal of Zopiclone
Zopiclone, like zolpidem, is under surveillance in France due to its potential for dependence, abuse and misuse. However, part of the narcotics regulation was implemented in 2017 in France for zolpidem only, which has led to an increase in the number of zopiclone consumers. The objective of this article is to present French addictovigilance data regarding the evolution of the abuse, dependence and misuse profiles of zopiclone. We used the followi…
Gabapentinoid Abuse in France
Introduction: Gabapentinoid drugs (gabapentin and pregabalin) are widely used worldwide for epileptic and pain disorders. First signals of gabapentinoid abuse occurred in the last decade. This study aims to describe clinical characteristics of gabapentinoid use related disorders and health consequences in France. Materials and Methods: We designed a multisource investigation reviewing data reported to the French Addictovigilance Network (FAN) wit…
Case Report
Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR
Overall, these results suggest a lack of awareness about medicinal product risks. Differences according to the place of residence are apparent and could be partly explained by a lower level of training of healthcare providers in contact with the population in the rural districts in particular. Communication on medicinal product risks to patients through well-trained healthcare providers could probably make a valuable contribution towards the appr…
No prominent works on this page.
Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR
Overall, these results suggest a lack of awareness about medicinal product risks. Differences according to the place of residence are apparent and could be partly explained by a lower level of training of healthcare providers in contact with the population in the rural districts in particular. Communication on medicinal product risks to patients through well-trained healthcare providers could probably make a valuable contribution towards the appr…
Case Report
Gabapentinoid Abuse in France
Introduction: Gabapentinoid drugs (gabapentin and pregabalin) are widely used worldwide for epileptic and pain disorders. First signals of gabapentinoid abuse occurred in the last decade. This study aims to describe clinical characteristics of gabapentinoid use related disorders and health consequences in France. Materials and Methods: We designed a multisource investigation reviewing data reported to the French Addictovigilance Network (FAN) wit…
Evolution of the Addictovigilance Signal of Zopiclone
Zopiclone, like zolpidem, is under surveillance in France due to its potential for dependence, abuse and misuse. However, part of the narcotics regulation was implemented in 2017 in France for zolpidem only, which has led to an increase in the number of zopiclone consumers. The objective of this article is to present French addictovigilance data regarding the evolution of the abuse, dependence and misuse profiles of zopiclone. We used the followi…
Healthcare use according to deprivation among French Alzheimer's Disease and Related Diseases subjects
Introduction: Pluriprofessional and coordinated healthcare use is recommended for Alzheimer's Disease and Related Diseases (ADRD). Despite a protective health system, France is characterized by persistent and significant social inequalities in health. Although social health inequalities are well documented, less is known about social disparities in healthcare use in ADRD, especially in France. Therefore, this study aimed to describe healthcare us…
Response to “Before a diagnosis of secondary catatonia due to chronic nitrous oxide use is made, all alternative causes must be ruled out”
International audience
First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use
Medicine (7 works) · Psychiatry (6 works) · Internal Medicine (4 works) · Environmental health (3 works) · Population (3 works) · Anesthesia (2 works) · Catatonia (2 works) · Comorbidity (2 works) · Electroconvulsive Therapy Studies (2 works) · Medical prescription (2 works)